(2R)-2,5-diamino-N-[(2R)-1-[[(2R)-1,5-diamino-1-oxopentan-2-yl]amino]-3-hydrazinyl-1-oxopropan-2-yl]pentanamide

C13H30N8O3 — CID 122462120

IUPAC(2R)-2,5-diamino-N-[(2R)-1-[[(2R)-1,5-diamino-1-oxopentan-2-yl]amino]-3-hydrazinyl-1-oxopropan-2-yl]pentanamide
SMILESNCCC[C@@H](N)C(=O)N[C@H](CNN)C(=O)N[C@H](CCCN)C(N)=O
InChIInChI=1S/C13H30N8O3/c14-5-1-3-8(16)12(23)21-10(7-19-18)13(24)20-9(11(17)22)4-2-6-15/h8-10,19H,1-7,14-16,18H2,(H2,17,22)(H,20,24)(H,21,23)/t8-,9-,10-/m1/s1
InChIKeyBAGALSSUAVAJDM-OPRDCNLKSA-N
MW346.44 g/mol
LogP-4.29
Rot. Bonds13

About (2R)-2,5-diamino-N-[(2R)-1-[[(2R)-1,5-diamino-1-oxopentan-2-yl]amino]-3-hydrazinyl-1-oxopropan-2-yl]pentanamide

(2R)-2,5-diamino-N-[(2R)-1-[[(2R)-1,5-diamino-1-oxopentan-2-yl]amino]-3-hydrazinyl-1-oxopropan-2-yl]pentanamide (PubChem CID 122462120) has the molecular formula C13H30N8O3 and a molecular weight of 346.44 g/mol. Its IUPAC name is (2R)-2,5-diamino-N-[(2R)-1-[[(2R)-1,5-diamino-1-oxopentan-2-yl]amino]-3-hydrazinyl-1-oxopropan-2-yl]pentanamide.

Molecular Properties

Compound Name(2R)-2,5-diamino-N-[(2R)-1-[[(2R)-1,5-diamino-1-oxopentan-2-yl]amino]-3-hydrazinyl-1-oxopropan-2-yl]pentanamide
PubChem CID122462120
Molecular FormulaC13H30N8O3
Molecular Weight346.44 g/mol
Exact Mass346.24
IUPAC Name(2R)-2,5-diamino-N-[(2R)-1-[[(2R)-1,5-diamino-1-oxopentan-2-yl]amino]-3-hydrazinyl-1-oxopropan-2-yl]pentanamide
SMILESNCCC[C@@H](N)C(=O)N[C@H](CNN)C(=O)N[C@H](CCCN)C(N)=O
InChIInChI=1S/C13H30N8O3/c14-5-1-3-8(16)12(23)21-10(7-19-18)13(24)20-9(11(17)22)4-2-6-15/h8-10,19H,1-7,14-16,18H2,(H2,17,22)(H,20,24)(H,21,23)/t8-,9-,10-/m1/s1
InChIKeyBAGALSSUAVAJDM-OPRDCNLKSA-N
XLogP-4.29
TPSA217.40 Ų
H-Bond Donors8
H-Bond Acceptors8
Rotatable Bonds13
Heavy Atoms24
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500346.44
LogP ≤ 5-4.29
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 108

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'hydrazine', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze (2R)-2,5-diamino-N-[(2R)-1-[[(2R)-1,5-diamino-1-oxopentan-2-yl]amino]-3-hydrazinyl-1-oxopropan-2-yl]pentanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2R)-2,5-diamino-N-[(2R)-1-[[(2R)-1,5-diamino-1-oxopentan-2-yl]amino]-3-hydrazinyl-1-oxopropan-2-yl]pentanamide?
The IUPAC name of (2R)-2,5-diamino-N-[(2R)-1-[[(2R)-1,5-diamino-1-oxopentan-2-yl]amino]-3-hydrazinyl-1-oxopropan-2-yl]pentanamide (CID 122462120) is (2R)-2,5-diamino-N-[(2R)-1-[[(2R)-1,5-diamino-1-oxopentan-2-yl]amino]-3-hydrazinyl-1-oxopropan-2-yl]pentanamide.
What is the SMILES notation for (2R)-2,5-diamino-N-[(2R)-1-[[(2R)-1,5-diamino-1-oxopentan-2-yl]amino]-3-hydrazinyl-1-oxopropan-2-yl]pentanamide?
The canonical SMILES for (2R)-2,5-diamino-N-[(2R)-1-[[(2R)-1,5-diamino-1-oxopentan-2-yl]amino]-3-hydrazinyl-1-oxopropan-2-yl]pentanamide is NCCC[C@@H](N)C(=O)N[C@H](CNN)C(=O)N[C@H](CCCN)C(N)=O.
What is the InChIKey of (2R)-2,5-diamino-N-[(2R)-1-[[(2R)-1,5-diamino-1-oxopentan-2-yl]amino]-3-hydrazinyl-1-oxopropan-2-yl]pentanamide?
The InChIKey is BAGALSSUAVAJDM-OPRDCNLKSA-N. The full InChI is InChI=1S/C13H30N8O3/c14-5-1-3-8(16)12(23)21-10(7-19-18)13(24)20-9(11(17)22)4-2-6-15/h8-10,19H,1-7,14-16,18H2,(H2,17,22)(H,20,24)(H,21,23)/t8-,9-,10-/m1/s1.
What are the key properties of (2R)-2,5-diamino-N-[(2R)-1-[[(2R)-1,5-diamino-1-oxopentan-2-yl]amino]-3-hydrazinyl-1-oxopropan-2-yl]pentanamide?
(2R)-2,5-diamino-N-[(2R)-1-[[(2R)-1,5-diamino-1-oxopentan-2-yl]amino]-3-hydrazinyl-1-oxopropan-2-yl]pentanamide has a molecular weight of 346.44 g/mol, XLogP of -4.29, 13 rotatable bonds, 8 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for (2R)-2,5-diamino-N-[(2R)-1-[[(2R)-1,5-diamino-1-oxopentan-2-yl]amino]-3-hydrazinyl-1-oxopropan-2-yl]pentanamide is sourced from PubChem (CID 122462120), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).